Efficacy Study of DeepDDH System in Screening Infants with Developmental Dysplasia of the Hip (DDH)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age28-6
SponsorRenJi Hospital

About this trial

To ascertain the efficacy of the DeepDDH system, a deep learning framework, in enhancing diagnostic accuracy and curtailing follow-up intervals for infants undergoing screening for developmental dysplasia of the hip (DDH), the researchers are executing a blinded, randomized controlled trial. This trial juxtaposes AI-only and AI-assisted assessments of DDH against sonographer interpretations across various proficiency levels in the preliminary analysis of ultrasound images.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Infants aged 28 days to 6 months who underwent DDH ultrasound examination in Renji Hospital, Shanghai Jiaotong University School of Medicine and the Sixth People's Hospital, Shanghai Jiaotong University School of Medicine between August 2014 and December 2021

Disqualifiers

Patients lacking or incomplete ultrasound images;

Patients with poor image quality and unusable images after assessment, including non-compliance with Anatomical identification (Checklist I consists of seven anatomical structures: 1. Chondro-osseous border, 2. Femoral head, 3. Synovial fold, 4. Joint capsule and perichondrium, 5. Labrum, 6. Cartilagineous roof, 7. Bony roof) and Usability check (Checklist II includes three anatomical landmarks: 1. Lower limb of the os ilium, 2. Parallel middle plane, and 3. Labrum);

Infants with hip dysplasia caused by other diseases such as cerebral palsy, joint contracture, suppurative coxitis, etc., or with other hip diseases and limb deformities.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Junior sonographer measurement of DDH

    Other intervention

    Participants will not receive visual cues from the DeepDDH system. Junior sonographer technicians will offer preliminary interpretations before these are subjected to validation and subsequent review by expert's team.

  • Senior sonographer measurement of DDH

    Other intervention

    Participants will not receive visual cues from the DeepDDH system.

  • Automated annotation of the DDH measurement through deep learning

    Other intervention

    Through randomization, a subset of the preliminary interpretations will be conducted by AI technology, and the study team will evaluate the degree of divergence between these AI-generated preliminary interpretations and the final interpretations.

  • AI-assisted junior sonographer meaturement of DDH

    Other intervention

    Participants will receive visual cues from the DeepDDH system.

Treatment groups

1,976 Participants
are divided into 4 treatment groups
Group A: Junior Sonographer AnnotationActive comparator 1 intervention
Group B: Senior Sonographer AnnotationActive comparator 1 intervention
Group C: DeepDDH system AnnotationExperimental treatment 1 intervention
Group D: DeepDDH-assist Junior Sonographer AnnotationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Average diagnostic accuracy

It is calculated by dividing the number of preliminary interpretations that are consistent with the expert team's grading by the total number of cases that should be diagnosed.

Time frame
30 Minutes

Secondary outcomes

1

Average diagnostic sensitivity

It is calculated by dividing the number of true positive cases by the sum of true positive cases and false negative cases.

Time frame
30 Minutes
2

Average diagnostic specificity

It is calculated by dividing the number of true negative cases by the sum of true negative cases and false positive cases.

Time frame
30 Minutes
3

Average times of follow-up visits

The average number of follow-up visits for each group is obtained by dividing the total number of follow-up visits for each participating infant within the group by the number of participating infants in that group. The specific calculation of follow-up visits is as follows: For each participating infant, if a false positive diagnosis is made and there are no more subsequent follow-up examination results, the number of follow-up visits is increased by 1; if a false negative diagnosis leads to the end of the follow-up process for the participating infant, then no further follow-up visits are counted.

Time frame
30 Minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: